CLARK IAN T 4
4 · Guardant Health, Inc. · Filed Jun 20, 2025
Insider Transaction Report
Form 4
CLARK IAN T
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-18+6,833→ 6,833 totalExercise: $50.57Exp: 2035-06-18→ Common Stock (6,833 underlying) - Sale
Common Stock
2025-06-17$48.38/sh−6,672$322,819→ 9,851 total(indirect: By Trust) - Award
Restricted Stock Units
2025-06-18+5,092→ 5,092 totalExercise: $0.00→ Common Stock (5,092 underlying)
Footnotes (4)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.38 to $48.41 per shares, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The stock option vests in full on the one-year anniversary of the grant date, June 18, 2025 or the date of the next year annual stockholders meeting, whichever is earlier.
- [F3]The restricted stock units vest in full on the one-year anniversary of the grant date, June 18, 2025 or the date of the next year annual stockholders meeting, whichever is earlier.
- [F4]Not applicable for Restricted Stock Units.